AAPL 195.34 -0.22 (-0.11%)MSFT 120.03 +1.13 (+0.95%)FB 166.05 +1.09 (+0.66%)ZNGA 5.42 -0.04 (-0.64%)NVDA 183.89 +1.36 (+0.75%)WBA 63.57 -0.19 (-0.30%)GOOG 1231.1 +7.88 (+0.64%)PIH 5.45 -0.16 (-2.85%)
AAPL 195.34 -0.22 (-0.11%)MSFT 120.03 +1.13 (+0.95%)FB 166.05 +1.09 (+0.66%)ZNGA 5.42 -0.04 (-0.64%)NVDA 183.89 +1.36 (+0.75%)WBA 63.57 -0.19 (-0.30%)GOOG 1231.1 +7.88 (+0.64%)PIH 5.45 -0.16 (-2.85%)

Financial Statements SELB Quote Selecta Bio

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Income Statement
Year 201420152016
Revenue 6 8 0
COGS 0 0 0
GrossProfit 6 8 0
Depreciation (included in COGS) 1 1 1
StockBasedCompe (included in COGS) 1 2 4
ResearchAndDeve 23 30 45
SalesGeneralAnd 8 13 19
OperatingIncome -25 -35 -64
InterestExpense 1 1 1
OtherIncome 1 0 0
IncomeBeforeTax -25 -36 -65
ProvisionForInc 0 0 0
NetIncome -25 -36 -65
Balance Sheet
Year 201420152016
CashAndCashEqui 32 59 71
ShortTermInvest 4 25 26
Cash 36 84 97
AccountReceivab 1 0 0
Inventories 0 0 0
DeferredIncomeT 0 0 0
OtherCurrentAss 0 0 0
TotalCurrentAss 39 87 99
PPE 5 6 6
AccumulatedDepr -3 -4 -4
NetPPE 2 2 2
EquityAndOtherI 0 0 0
Goodwill 0 0 0
IntangibleAsset 0 0 0
OtherLTAssets 2 0 0
TotalNonCurrent 4 2 2
TotalAssets 43 89 101
ShortTermDebt 0 4 0
AccountsPayable 2 4 2
TaxesPayable 0 0 0
AccruedLiabilit 2 2 7
DeferredRevenue 1 2 1
OtherCurrentLia 1 2 2
TotalCurrentLia 7 14 11
Debt 12 8 21
DeferredTaxesLi 0 0 0
DeferredRevenue 2 12 16
OtherLTLiabilit 138 0 1
TotalNonCurrent 152 21 38
TotalLiabilitie 159 34 49
CommonStock 0 0 0
AdditionalPaidI 0 211 273
RetainedEarning -112 -152 -217
AccumulatedOthe -5 -5 -4
TotalStockholde -116 55 52
TotalLiabilitie 43 89 101
Cash Flow Statement
Year 201420152016
NetIncome -25 -36 -65
Depreciation 1 1 1
DeferredIncomeT 0 0 0
StockBasedCompe 1 2 4
AccountsReceiva 0 1 0
InventoryCS 0 0 0
AccountsPayable 1 3 -2
OtherWorkingCap 0 10 3
OtherNonCashIte 0 0 1
NetCashProvided -22 -20 -52
InvestmentsInPP -1 -1 -1
AcquisitionsNet 0 0 0
PurchasesOfInve 0 -28 -62
SalesMaturities 0 0 0
PurchasesOfInta 0 0 0
OtherInvestingA -4 7 60
NetCashUsedForI -5 -22 -2
DebtIssued 14 0 21
DebtRepayment -2 0 -13
CommonStockIssu 0 72 57
CommonStockRepu 0 0 0
DividendPaid 0 0 0
OtherFinancingA 0 -4 1
NetCashProvided 44 68 66
NetChangeInCash 16 26 12
CashAtBeginning 17 32 59
CashAtEndOfPeri 32 59 71
Retained Earnings
Year 201420152016
RetainedEarning ---84
NetIncome --13-25
StockDividend -9753
DividendPaid ---
RetainedEarning --84-112
Property Plant and Equipment Schedule
Year 201420152016
NetPPE --2
DeprAnnual 0-3-
CapitalExpendit 001
NetPPE -22
Intangible and Goodwill Schedule
Year 201420152016
intAndGW 0--
Amortization 02-1
NewPurchases 0-21
intAndGW ---
Selecta Biosciences Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Selecta Biosciences Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.